# The Impact on Survival of Neo-adjuvant Transarterial Chemoinfusion (TAI) for Patients With Hepatocellular Carcinoma And Portal Vein Tumor Thrombosis (PVTT) Who Underwent Hepatectomy : A Random, Controlled, Stage III Clinical Trial.

> **NCT03368651** · PHASE3 · RECRUITING · sponsor: **Sun Yat-sen University** · enrollment: 230 (estimated)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **PROCEDURE:** TAI

## Key facts

- **NCT ID:** NCT03368651
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2016-01-01
- **Primary completion:** 2026-11-30
- **Final completion:** 2028-12-31
- **Target enrollment:** 230 (ESTIMATED)
- **Last updated:** 2017-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03368651

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03368651, "The Impact on Survival of Neo-adjuvant Transarterial Chemoinfusion (TAI) for Patients With Hepatocellular Carcinoma And Portal Vein Tumor Thrombosis (PVTT) Who Underwent Hepatectomy : A Random, Controlled, Stage III Clinical Trial.". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03368651. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*